Abstract: The invention provides a particle comprising a first semiconductor and a second semiconductor wherein the first semiconductor forms a heterojunction with the second semiconductor. The invention also provides a pharmaceutical composition comprising the particles, and relates to uses of the particles and composition in the treatment of cancer in combination with radiotherapy.
Type:
Application
Filed:
November 16, 2018
Publication date:
September 3, 2020
Applicant:
Xerion Healthcare Limited
Inventors:
Matthew Ronald Phillip Stock, Martin Ryan Gardener, Gareth Wakefield